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Abstract
Background: Heat shock proteins (Hsps) are a set of highly conserved proteins, Hsp105, has been
suggested to play a role in reproduction.
Methods: Spatio-temporal expression of Hsp105 in rat uterus during peri-implantation period was
examined by immunohistochemistry and Western blot, pseudopregnant uterus was used as
control. Injection of antisense oligodeoxynucleotides to Hsp105 into pregnant rat uteri was carried
out to look at effect of Hsp105 on embryo implantation.
Results: Expression of Hsp105 was mainly in the luminal epithelium on day 1 of pregnancy, and
reached a peak level on day 5, whereas in stroma cells, adjacent to the implanting embryo, the
strongest expression of Hsp105 was observed on day 6. The immunostaining profile in the uterus
was consistent with that obtained by Western blot in the early pregnancy. In contrast, no obvious
peak level of Hsp105 was observed in the uterus of pseudopregnant rat on day 5 or day 6.
Furthermore, injection of antisense oligodeoxynucleotides to Hsp105 into the rat uterine horn on
day 3 of pregnancy obviously suppressed the protein expression as expected and reduced number
of the implanted embryos as compared with the control.
Conclusion: Temporal and spatial changes in Hsp105 expression in pregnant rat uterus may play
a physiological role in regulating embryo implantation.
Background
Heat shock proteins (Hsps) have been identified in all
eukaryotic and prokaryotic organisms[1]. They may act as
molecular chaperones by preventing aggregation and
assisting refolding of misfolded proteins [2-4]. Hsps could
be induced in response to a physiological effect or envi-
ronmental effect of stress, such as elevation in tempera-
ture, oxidative stress, viral infection, nutritional
deficiency, or toxic chemical exposure [5,6]. On the basis
of molecular weight, mammalian Hsps have been classi-
fied into various families, including Hsp105, 90, 70, 60,
and other small Hsps [4,7]. The 105 kDa protein is one of
the major mammalian Hsp which belongs to the family of
higher molecular mass, and is composed of 858 amino
acid residues [8]. Hatayama et al. [9] demonstrated a role
of this protein in protecting neuronal cells against stress-
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induced apoptosis in rat neuronal PC12 cells, suggesting
that this protein may be a novel anti-apoptotic neuropro-
tective factor in the mammalian brain [10,11]. Increasing
evidences indicate that Hsps could regulate cell apoptosis
either by directly promoting cell apoptosis or by inhibit-
ing apoptotic response as a chaperone of a key signaling
protein [12,13]. We have demonstrated that Hsp105 was
expressed in monkey testis and may play an important
role in regulation of germ cell apoptosis induced by heat
stress [14]. Hsp105 may function as a pro-apoptotic factor
[15] or as an anti-apoptotic factor depending on cell type
in mammals [16].
The evidences from our previous studies both on rhesus
monkey and human being demonstrated that a relatively
high frequency of apoptosis occurs in the secretory
endometrium, correlated to the period of formation of
implantation window [17] which was a limited period of
endometrial receptivity to blastocyst stimulus[18,19]. The
time surrounding the window of receptivity in the rat is
referred to as the peri-implantation period and involves
days 4, 5, and 6 of pregnancy. In response to implanting
embryos the underlying endometrial stromal cells
undergo decidualization that involves proliferation and
differentiation through cell division and apoptosis
[20,21]. Apoptosis is a physiological process which
remodels tissue by removing expendable cells without
allowing the entry of proteolytic enzymes and other
harmful or corrosive substances into the surrounding tis-
sue, and thus reducing the likelihood of an inflammatory
response[22,23].
Localization of apoptotic cells in relation to the expres-
sion of apoptosis-related molecules, such as Fas/FasL, Bcl-
2/Bax, and P53 have been demonstrated in the materno-
fetal boundary of rhesus monkeys in pregnancy [24,25].
Apoptotic nuclei were observed mainly in the glandular
cells and the blood vessel endothelial cells in decidua
[26]. A transient increase in Hsp105 expression during
mouse embryogenesis was observed in the embryonic tis-
sues [9]. Human endometrium [27], deciduas [28,29] and
trophoblast tissues have been also reported to be capable
of expressing Hsps during the first trimester of preg-
nancy[30,31], however, to the best of our knowledge, no
studies about an action of Hsp105 in mammalian uterus
during implantation have been reported. In the present
study, we have analyzed Hsp105 protein expression in rat
uterus of early pregnancy, and examined the effect of
injection of antisense Hsp105 oligodeoxynucleotides into
the pregnant uterine horn on embryo implantation.
Methods
Animals
Spague Dawley rats were obtained from the Animal Facil-
ity of Institute of Zoology, Chinese Academy of Sciences.
The Guidelines for the Care and Use of Animals in
Research enforced by Beijing Municipal Science and Tech-
nology Commission were followed. All protocols have
been approved by the Animal Care and Use Committee of
Institute of Zoology, Chinese Academy of Sciences. The
rats were caged in a controlled environment with a 14 hr
light:10 hr dark cycle. The adult females were mated with
fertile males of the same strain to induce pregnancy (day
1, D1 = day of vaginal plug positive). Pregnancy on D1–5
was confirmed by flushing embryos from the reproductive
tracts. The implantation sites on D6–7 were identified by
intravenous injection of 1% (w/v) trypan blue (Sigma
Chemical Company, St. Louis, MO) in 0.85% (w/v)
sodium chloride, according to the procedures described
by Chun et al. and Xiao et al. [32,33]. In several experi-
ments, some male rats were vasectomized, and after 14
days they were used to mate with females to induce
pseudo-pregnancy (PD, PD1 = day of vaginal plug posi-
tive).
Immunohistochemistry
In the designed time points the animals were killed by cer-
vical dislocation under anaesthetic and the uteri were col-
lected. In some experiments the implantation sites on day
6 and 7 were separated from the inter-implantation seg-
ments, the corrected uterine materials were fixed immedi-
ately in 10% neutral buffered formalin solution (Beijing
Chemical Reagents Co. Beijing, China) overnight, and
then embedded in paraffin. Serial 5 μm sections of the
uterine tissues were deparaffinized and rehydrated
through degraded ethanol. Antigen retrieval was per-
formed by incubating the sections in 0.01 M citrate buffer
(pH 6.0) at 98°C for 20 min, followed by cooling at room
temperature for 20 min. Non-specific binding was
blocked with 5% (v/v) normal goat serum (Santa Cruz
Biotechnology, Inc) in PBS for 1 h. The sections were incu-
bated with the primary antibodies against Hsp105 (sc-
6241, Santa Cruz Biotechnology, Santa Cruz, CA 1: 200)
in 10% goat serum overnight at 4°C. The sections were
then washed three times with PBS (10 min each) and
incubated with biotin labeled secondary antibody (goat
anti-rabbit IgG, RT, 30 min, 1:200), After three times
washes with PBS, the sections were incubated with avidin-
AP complex (1:200, RT, 20 min). After three more washes,
the sections were developed with Vector Red AP substrates
according to the manufacturer's protocol (Vectastain
ABCAP kit, Vector Laboratories, Burlingame, CA). Endog-
enous AP activity was inhibited by supplement of 1 mM
levamisole (Sigma Corp., St. Louis, MO) into the sub-
strate. The sections stained with Vector Red substrates
were counter-stained with haematoxylin. The sections
incubated with normal IgG instead of the primary anti-
body served as the negative controls.Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
Page 3 of 10
(page number not for citation purposes)
Western blot analysis
The uteri from various groups were homogenized respec-
tively in the lysis buffer (5 mmol/L phosphate buffer, pH
7.2, containing 0.1% Triton X-100, 1 mM phenylmethyl-
sulfonylfluoride, and 1 mg/L chymostatin), and the con-
centration of protein in the supernatant after
centrifugation was determined by UV spectrophotometer.
The sample lysates in each group were mixed with the
loading buffer (62.5 mM 1,4- dithiothreitol, 5% sodium
dodecyl sulfate (SDS), and 10% glycerol), boiled for 8
min, and then separated by SDS-polyacrylamide gel elec-
trophoresis (PAGE) (50 μg total protein/lane). The sepa-
rated proteins were transferred electrophoretically onto a
pure nitrocellulose blotting membrane (Pall Corporation,
Pensacola, FL), and then incubated with blocking buffer
(3% BSA (v/v) in TBST for 1 h at room temperature. The
membrane was subsequently incubated with the anti-
Hsp105 antibodies overnight at 4°C, washed for three
times with TBST, 15 min each time, and further incubated
for 1 h at room temperature with TBST containing alkaline
phosphatase-conjugated secondary antibodies, and then
washed three times with TBST. After one more time of
wash with TBS, then the membrane was subjected to an
alkaline phosphatase color reaction by a standard
method. Actin protein was used as the internal control for
cytosolic protein. Band intensity was determined by
Quantity One Software (Bio-Rad, Hercules, CA).
Design of oligodeoxynucleotides specific sequence for 
Hsp105
The sequence(s) of oligodeoxynucleotides (ODNs) (16
nucleotides in length) were: sense oligodeoxynucle-
otides(S-ODNs):5'-AGCCATGTCGGTGGTT-3, antisense
oligodeoxy- nucleotides (A-ODNs): 5'-AACCACCGACAT-
GGCT-3'. The A-ODNs were complementary to bases
191–206 bp within exon I of the rat Hsp105 (GenBank
Accession Number: NM_001011901). All the sequences
were thiophosphate-modified for their long half-lives in
cells. FITC/A-ODNs and FITC/S-ODNs are FITC-conju-
gated ODNs at the 3' end. All the ODNs were synthesized
by SBS Genetech Co., Ltd. (Beijing, China). Analysis of
homology between the synthesized oligomer and the
rodent sequences present in the GenBank data bases
(release 73.0) by the Genetics Computer Group sequence
analysis software package revealed that the synthetic oli-
gomers were fully complementary only to their own spe-
cific mRNA.
Tracking of FITC- labeled ODNs in the tissue of rat uterus
Pregnant rats were injected with Hsp105 S-ODNs or A-
ODNs according to the procedures described by Zhu et al.
[34]. Tracking of FITC-labeled ODNs was performed
according to the procedures described by Luu et al. [35].
Uterine penetration of the ODNs and cross-contamina-
tion between the two horns were assessed by injecting 10
μg (in 100 μL distilled water) of FITC-A-ODNs or FITC-S-
ODNs into one horn, with either unlabeled standard con-
trol A-ODNs or S-ODNs alone into the contralateral horn
of the uterus. The uteri were excised and frozen in OCT
compound (QIAGEN N.V.) at 2.5 h, 24 h and 48 h after
injection of the ODNs. 6 μm thick frozen sections were
then analyzed under a fluorescence microscope at 488
nm.
The ODNs experiments were carried out in the afternoon
on day 3 of pregnancy. The animals were divided into two
groups, each group (n = 12/ODNs pair, 6 for S-ODNs and
the other 6 for A-ODNs) was subject to a surgical opera-
tion and each uterine horn was injected with 10 μg of A-
ODNs targeted against exon I of the Hsp105 or the corre-
sponding S-ODNs or double distilled water (DD water).
The animals were killed at 24 h and 48 h, respectively,
after the operation, the uteri were fixed immediately for
overnight in 10% neutral buffered formalin solution (Bei-
jing Chemical Reagents Co. Beijing, China) and embed-
ded in paraffin. Serial 5 μm sections of the uterine tissues
were deparaffinized and rehydrated through graded etha-
nol for immunohistochemical analysis.
Microscopic assessment and statistical analysis
The uterine samples from 3 rats in each group were ana-
lyzed. Experiments were repeated at least three times,
from which one taken from at least three similar results
was presented as a representative of the immunocyto-
chemical data in the group. Signal intensities of Hsp105
detected by immunohistochemistry were quantified by
computer-aided laser-scanning densitometry (Personal
Densitometer SI; Molecular Dynamics, Inc., Sunnyvale,
CA). In order to make the statistical significance of quan-
titative difference credible, three slides from each of six
animals of each group were examined (n = 6), and 40
spots were randomly selected in every specific location of
the specific cell types. The gray level of intercellular sub-
stance was considered as background. Statistical analysis
was carried out with SPSS (version 10.0, SPSS Inc., Chi-
cago, IL), and one-way ANOVA was used followed by
Post-Hoc comparisons for analyzing the data in different
groups. P values lower than 0.05 were considered statisti-
cally significant. To estimate specific staining in various
cells of the uteri, a semi-quantitative subjective scoring
was also performed by three blinded investigators using a
4-scale system with – (nil), +/- (weak), + (moderate), and
++ (strong), as described by Yue et al. [36]. The statistical
data of Western blot from three individual experiments
were analyzed by using Statistical Package for Social Sci-
ence (SPSS for Windows package release 10.0, SPSS Inc.,
Chicago, IL). Statistical significance was determined by
one-way ANOVA. Post-Hoc comparisons between groups
were made using Fisher's protected least-significance-dif-
ference test. Values were means ± SEM. P values lower
than 0.05 were considered statistically significant.Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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Results
Hsp105 expression in rat uterus during early pregnancy
In order to examine developmental expression of Hsp105
in rat uterus of normal pregnancy, we performed immu-
nohistochemistry using an antibody against rat Hsp105
protein. The results showed that Hsp105 expression was
mainly localized in the luminal epithelium on day 1 of
pregnancy (Fig. 1, D1), and increased in the glandular epi-
thelium on days 2 and 3 (Fig. 1, D2). On days 4 and 5,
additional staining was observed in the stromal cells
immediately underneath the luminal epithelium, reach-
ing a peak level on day 5 (Fig. 1, D4, D5). The strongest
expression of this protein was detected in the decidual
cells adjacent to the implanting embryo on day 6 (Fig. 1,
D6). Localization and average score of Hsp105 protein at
the various uterine locations are summarized in Table 1.
Western blot analysis of Hsp105 expression in uterus 
during early pregnancy
The quantitative change in uterine Hsp105 expression was
estimated by Western blot, as shown in Fig. 2. The protein
level in the uterus was increased in a time-dependent
manner, the highest expression was observed on day5 and
day 6, just around the time before and after implantation.
Hsp105 expression in rat uterus during pseudo-pregnancy
To further confirm specific expression of Hsp105 in rela-
tion to implantation, we performed an experiment with
pseudopregnant rats. The protein was mainly localized in
the luminal epithelium on day 1 (Fig. 3, PD1), with the
staining increased in both the luminal and the glandular
epithelium on day 2 and 3 (Fig. 3, PD2, PD3), sharply
decreased on day 4, and remaining at a low level on day 5
to 7 (Fig. 3, PD4, PD5, PD6, PD7). No peak level expres-
sion of this protein was observed in the pseudopregnant
uterus. The score of the specific cell staining for Hsp105 in
the uterus during pseudopregnancy is summarized in
Table 2.
Comparison of Hsp105 protein expression in uterus 
between implantation site and inter-implantation segment
In order to know whether Hsp105 expression is related to
implantation, we analyzed its expression in both implan-
tation site and the inter-implantation segment on day 6 by
immunohistochemistry. The results showed that the
Immunohistochemistry of Hsp105 in rat uterus during early pregnancy Figure 1
Immunohistochemistry of Hsp105 in rat uterus during early pregnancy. Hsp105 protein was observed mainly in the 
luminal epithelium on day 1 of pregnancy (D1) and moderately expressed in the luminal epithelium and the glandular epithelium 
from day 2 to day 3 (D2). Hsp105 staining was also detected in the stromal cells, immediately underneath the luminal epithe-
lium on day 4 and day 5 of pregnancy (D4, D5), the staining was increased markedly on day 5 just before implantation (D5). On 
day 6, the protein staining was mainly observed in the implanted blastocyst and the stromal cells around the implantation site 
(D6), while its expression in the luminal epithelium reduced to an undetected level. CON, negtive control; le, luminal epithe-
lium; ge, glandular epithelium; s, stroma; de, decidua; em, embryo. Bar = 200 μm.Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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expression of this protein at the implantation site (Fig. 4,
D6m) was much stronger than that in the interimplanta-
tion segment (Fig. 4, D6n), as summarized in Table 3.
Suppression of Hsp105 expression in pregnant rat uterus 
by antisense ODNs
Using an A-ODNs as a blocker we examined effect of
blockage of Hsp105 gene expression on rat implantation.
To assess A-ODNs penetrating capacity, the Hsp105 FITC-
ODNs was first injected into the uterine lumen, and then
the uteri were taken for preparing sections at the indicated
time points for FITC-ODNs examination by fluorescence
microscopy. Strong green fluorescence representing cellu-
lar uptake of FITC-ODNs was observed in the luminal epi-
thelium at 2.5 hours after injection (Fig. 5A). A detectable
fluorescence in the underlying stroma was detected 48
hours later (Fig. 5B), indicating the penetration of Hsp105
ODNs into these cells in vivo. No fluorescence was
observed in the contralateral horn treated with the unla-
beled ODNs as the control (Fig. 5C).
Based on Hsp105 expression profile in the uterus, the
time window of Hsp105 ODNs administration should be
between days 3 and 5 of gestation for allowing blockage
of its protein expression. The pregnant rat uteri were
injected with either DD water, or Hsp105  S-ODNs or
Hsp105 A-ODNs on day 3 of pregnancy, the uteri were col-
lected 24 h and 48 h later, and then subjected to immu-
nostaining analysis. As shown in Fig. 6A (a, b), an
intensive staining was observed mainly in the luminal epi-
thelium and glandular epithelial cells in the uterus treated
with water and S-ODNs respectively. In contrast, the con-
tralateral horn treated with A-ODNs showed only low
level of Hsp105 staining on day 4, 24h after injection of
ODNs (Fig. 6A (c)). A marked decrease in Hsp105 immu-
nostaining was noted on day 5 after treatment with A-
ODNs (data not shown). Statistical analysis by the com-
puter-aided laser-scanning densitometry showed that the
Hsp105 levels between the uteri treated with DD water, S-
ODNs and A-ODNs were significant different in the lumi-
nal epithelium and the glandular epithelium (Fig. 6B).
Decreasing number of implanted embryos by antisense 
Hsp105 ODNs treatment
We further examined whether inhibition of Hsp105
expression could influence embryo implantation. After
Table 1: Semi-quantitative estimation of Hsp105 expression in 
the various uterine cells during early pregnancy
Days of early pregnancy
Cell Types 1 2 3 4 5 6
Luminal epithelium + + + + ++ -
Glandular epithelium +/- + + + +++ -
Stromal cells + +++ -
Primary Deciduas +++
Embryo +++
Secondary Deciduas +++
Western blot analysis of Hsp105 protein in uterus during early pregnancy Figure 2
Western blot analysis of Hsp105 protein in uterus during early pregnancy. A: Representative Western Blot analysis 
of Hsp 105 protein. Actin protein was used as an internal control. B: The bar graph represents the densitometric analysis of the 
Hsp 105. The relative intensity was determined by the ratio of Hsp105 protein to its corresponding internal control as meas-
ured by densitometry. Data are presented as mean ± SEM (n = 3). Statistical analysis was performed using one-way ANOVA 
followed by the Fisher's protected least-significance-difference test. Bar with ** is significantly different from D1 of pregnancy 
(P < 0.01).Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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administration of either the antisense or the correspond-
ing sense Hsp105 ODNs or distilled water into the respec-
tive unilateral uterine horns of pregnant rats on day 3, the
animals were killed on day 9, and the uteri were examined
for the number of implanted embryos as well as their
morphological status. One representative picture of the A-
ODNs- and the S-ODNs-treated uteri was shown (Fig.
7A). Ten and 9 embryos were observed in the S-ODNs-
treated horns (n = 8) (a: left horn, b: right horn), while
only 3 and 4 embryos (a: right horn, b: left horn) were
observed in the contralateral A-ODNs-treated horns.
However, all the embryos in both treated horns were nor-
mal by appearance and size. The water-injected rats con-
tained eight to ten normal implanted embryos in each
uterine horn in average (Fig. 7A(c)). No significant
changes in the number of implanted embryos or the
embryo normality were observed in the S-ODNs-treated
horns as compared with that in the water-treated control
group, indicating that the dose of ODNs used in this study
was non-toxic to the embryo implantation. In contrast, as
shown in Fig. 7B, a significant reduction in the number of
implanted embryos in the A-ODNs-treated group was
observed (60%, P < 0.01) as compared with that of the S-
ODNs-treated group, but no embryo abnormality in the
A-ODNs treated animals was observed.
Discussion
The results of the present study indicate that time-depend-
ent expression of Hsp105 in the uterine luminal, glandu-
lar epithelium and stromal cells during periimplantation
period might be essential for regulation of embryo
implantation. Our data also show that the presence of
embryo in uterus as a stimulus may be important for
increasing Hsp105 expression. If Hsp105 is involved in
regulation of endometrial differentiation for embryo
implantation, one may expect that a reduction of its
expression could prevent acquisition of receptive state of
the endometrium leading to a failure of implantation.
Therefore, we designed an experiment with Hsp105 anti-
sense oligodeoxynucleotides directly injecting into preg-
nant rat uterus at early pregnancy, which allowed us to
investigate a function of this protein in the process of
implantation. Technically, it would be important to do
such an experiment to know the transient nature of
Hsp105 gene expression in the uterus. In order to select an
appropriate time window of ODNs administration for
blockage of Hsp105 expression, we reasoned that the time
window should be immediately preceding that of Hsp105
induction, i.e., between days 3 and 6 of gestation. The pre-
cise half-life of the Hsp105 mRNA or its protein in uterus
has not yet been determined, nevertheless, the modified
Immunohistochemistry of Hsp105 during pseudopregnancy Figure 3
Immunohistochemistry of Hsp105 during pseudopregnancy. The adult male animals were vasectomized and 14 days 
later were used to mate with the adult females of the same strain to induce pseudo-pregnancy (pseudo-pregnancy day 1 (PD1) 
= day of vaginal plug positive). Hsp150 protein was mainly detected in the luminal epithelium on day 1 (PD1). The protein stain-
ing was increased in the luminal epithelium and glandular epithelium from day 2 to 3 (PD2, PD3). The protein expression was 
decreased from day 4 to 7 (PD4, PD5, PD6, PD7). CON, negtive control from day 2 of pseudopregancy; le, luminal epithelium; 
ge, glandular epithelium; s, stroma. Bar = 200 μm.
Table 2: Semi-quantitative estimation of Hsp105 expression at 
the various uterine cells during pseudopregnancy
Days of pseudopregnancy
C e l l  T y p e s 1 2 3 4567
Luminal epithelium + + + +/- +/- +/- +/-
Glandular epithelium +/- + + +/- +/- +/- +/-
Stromal cells - - - - - - -Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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Hsp105 ODNs are known to have a half life of 24–48
hours in certain tissues [37]. Therefore, ODNs were
designed for injection in the afternoon of day 3 of preg-
nancy, one may expect the tissue on observation to survive
for the subsequent 3–4 days of gestation, for an effective
suppression of the surge of Hsp105 expression. Because
rat embryos were observed to be also capable of express-
ing Hsp105 (unpublished data), we examined a potential
effect of ODNs on embryonic development by observing
its normality. Therefore we selected a much later time
point (Day 9) to count and examine the embryos. The sta-
tistical analysis of the difference of the numbers of
implanted embryo between the antisense- and the sense
ODNs-treated groups indicated that embryo implantation
was indeed prohibited by the antisense ODNs (P < 0.01).
These results together with the other observations suggest
that treatment with antisense Hsp105 ODNs, but not with
complementary sense ODNs, could severely impair the
process of embryo implantation, but no effect on the nor-
mality of implanted embryos was observed on day 9 of
pregnancy. However, Nakamura et al. just recently gener-
ated the Hsp105 knockout mice which did not appear a
problem with reproduction [38], implying that Hsp105
may be not the necessary gene required for implantation
in mouse. However, the authors did not specifically pay
attention to examine if the animals had any implantation
defect present. Hsp105 family has another two members,
APG1 and APG which have shown a similar function with
Hsp105, and may rescue its function in the absence of
Hsp105. We have demonstrated previously that plas-
minogen activator is important in ovulation of rat and
monkeys both in vivo and in vitro[39], however, double
knockout of tPA and uPA in mice showed only 26% inhi-
bition of ovulation could be observed[40]. Our further
studies showed that mouse ovary produces not tPA and
uPA, but also MMPs which have also shown to play a role
in ovulation. It is possible that MMPs could rescue the
Immunohistochemistry of Hsp105 in implantation site and inter-implantation segment Figure 4
Immunohistochemistry of Hsp105 in implantation site and inter-implantation segment. The pregnant rats were 
killed on Day 6, the implantation sites (D6m) and the inter-implantation segments (D6n) were isolated for preparation of 
immunohistochemistry. Hsp105 expression in endometrium at the implantation site was much stronger than that at the inter-
implantation segment. CON, negtive control; le, luminal epithelium; ge, glandular epithelium; s, stroma; de, decidua; em, 
embryo. Bar = 200 μm.
Table 3: Semi-quantitative estimation of Hsp110 expression at 
the various uterine cells in implantation site and 
interimplantation segment on day 6 of pregnancy
Cell Types Implantation site Interimplantation segment
Luminal epithelium - +
Glandular epithelium - +
Primary decidua +++
Embryo +++
Secondary decidua +++
Fluorescence micrographs of rat uteri after intrauterine  administration of FITC-ODNs Figure 5
Fluorescence micrographs of rat uteri after intrau-
terine administration of FITC-ODNs. (A) The uterine 
horn treated with FITC- ODNs (either sense or antisense) 
displaying high level of fluorescence only in the luminal epi-
thelium 2.5 hours after administration. (B) 48 hours later, a 
moderate fluorescence in the stromal compartment was 
observed after treatment with FITC- ODNs (either sense or 
antisense). (C) Uterine horn treated with unlabeled control 
A-ODNs displaying no fluorescence. le, luminal epithelium; s, 
stroma. Bar = 100 μm.Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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function in absence of tPA or uPA. Implantation is a very
complex event, which involves various processes, such as
blastocyst adhesion, trophoblast invasion, decidualiza-
tion and cell-to-cell interaction, controlled by a variety of
molecules produced by endometrium, embryo and ovary
[41]. During mammalian implantation stroma of the
endometrium undergoes severe remodeling, involving
apoptosis, proteolysis and angiogenesis [41,42]. Endome-
trial cells rapidly proliferate and differentiate to form the
decidua tissue which accommodates and protects
implanted embryos [43]. In our previous reports, analysis
of the endometrium of both rhesus monkey and human
during peri-implantation period has demonstrated that a
relatively high frequency of apoptosis occurs in the secre-
tory endometrium and is correlated to increased expres-
sion of apoptosis related molecules [25,26], while only
limited numbers of the apoptotic cells were observed in
the other phases of the cycle. It appears that endometrial
apoptosis and the cyclic changes in endometrial growth
and regression during establishment of implantation win-
dow might be regulated precisely and coordinately, not
only by Fas, FasL, BcL-2 and Bax [17], but also by Hsp105,
because the profile of these molecules is well correlated
with that of the Hsp105 expression in rat uterus as dem-
onstrated in the present study. Evidence has shown that
Hsp105 is capable of enhancing cell apoptosis in mouse
embryonal F9 cells[15,44] and murine embryos during
embryogenesis[9,45]. On the contrary, the Hsp protein
was also observed to inhibit cell apoptosis in rat testis and
some experimental cell models [16,46-48]. These observa-
tions suggest that Hsp105 may be involved in regulation
of murine uterine cell apoptosis. Since the cell types, spe-
cies used in the individual studies were different, some
unknown factors as well as cellular environment present
in the various studies might determine an inhibitory or a
promotional effect of the Hsp protein on cell apoptosis.
Hsp 105 immunohistochemistry staining analysis of the preg- nant rat uterus after antisense or sense ODNs treatment Figure 6
Hsp 105 immunohistochemistry staining analysis of 
the pregnant rat uterus after antisense or sense 
ODNs treatment. A: The figure was one representative 
from at least three similar independent experiment results. 
The immunohistochemistry staining was greatly decreased 
when the uteri were treated with A-ODNs (c) as compared 
with S-ODNs (b) and DD water (a). B: Statistical analysis of 
Hsp105 protein level in the uterus treated with DD water, S-
ODNs or A-ODNs. Data are presented as mean ± SEM (n = 
6). Statistical analysis was performed using one-way ANOVA 
followed by Post-Hoc comparisons. Bar with ** is signifi-
cantly different from S-ODNs treated and DD water treated 
control (P < 0.01). le, luminal epithelium; ge, glandular epithe-
lium; s, stroma. Bar = 200 μm.
Effect of antisense ODNs on number of implanted embryo Figure 7
Effect of antisense ODNs on number of implanted 
embryo. A: Three representative uteri: (a) Pregnant rat was 
injected with sense Hsp105 ODNs in the left horn, with anti-
sense Hsp105 ODNs in the right horn (10 ug in100 μl DD 
water) on day 3 of pregnancy; (b): Pregnant rat was injected 
in the left horn with antisense, the right horn with sense 
Hsp105 ODNs (10 ug in 100 μl DD water) on day 3 of preg-
nancy; (c): Pregnant rat was injected in both horns with DD 
water (100 μl). B: Statistical analysis of implanted embryo 
numbers in the uteri with the various treatments. Vertical 
axis represents the number of implanted embryos in the uni-
lateral uterine horn. Data are presented as mean ± SEM (n = 
8). Statistical analysis was performed using one-way ANOVA 
followed by Post-Hoc comparisons Bar with ** is significantly 
different from S-ODNs and DD water treated control (P < 
0.01).Reproductive Biology and Endocrinology 2009, 7:23 http://www.rbej.com/content/7/1/23
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However, the molecular mechanism of Hsp105 in regulat-
ing uterine cell apoptosis during rat periimplantation
period remains to be further investigated. In summary,
our data have demonstrated a significant increase in
Hsp105 expression on day 5. It seems that the protein
might be able to induce luminal cell apoptosis which in
turn destabilizes epithelial barrier at implantation site and
facilitates trophoblast invasion and implantation. On D6
of pregnancy Hsp105 expression was down-regulated in
luminal epithelium, and upregulated in stroma cells adja-
cent to the embryo attachment. The dynamic changes in
the level of expression of this protein during early implan-
tation period suggest involvement of this protein in cer-
tain cellular events in luminal epithelial and stromal cells,
which are essential for implantation.
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